IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
Clinical trial NCT06513429 · RECRUITING
Trial details
- NCT number
- NCT06513429
- Sponsor
- Peking University Third Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2025-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.